Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12CANCER RESEARCH AND TREATMENT, 2021, v.53 no.3, 671-677
Choosing Wisely: The Korean Perspective and Launch of the 'Right Decision in Cancer Care' InitiativeCANCER RESEARCH AND TREATMENT, 2020, v.52 no.3, 655-660
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12Journal of Cancer Research and Clinical Oncology, 2020, v. 146 no.12, 0
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)CANCERS, 2020, v.12 no.11, 3265
Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen speciesMolecules and Cells, 2020, v.43 no.9, 813-820
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)BMC CANCER, 2020, v.20 no.1, 813
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trialLANCET ONCOLOGY, 2019, v.20 no.12, 1750-1759
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)GASTRIC CANCER, 2018, v.21 no.5, 819-830
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Cancer, 2017, v. 123 no.11
The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cellsONCOLOGY LETTERS, 2017, v.14 no.1, 276-282
A retrospective analysis for patients with HER2-positive gastric cancer who were treated with trastuzumab-based chemotherapy: In the perspectives of ethnicity and histologyCancer Research and Treatment, 2016, v.48 no.2, 553-560
Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case ReportChemotherapy, 2016, v.62 no.1, 54-57
MITOCHONDRIAL SPECIFIC ROS HYPEROXIDATION VIA PEROXIREDOXIN III HAS IMPORTANT ROLES ON ARSENIC TRIOXIDE INDUCED APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIAHAEMATOLOGICA, 2016, v.101, 672-672
The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe painKorean Journal of Internal Medicine, 2015, v.30 no.1, 88-95
Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancerTUMORI, 2014, v.100 no.1, 80-86